You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 5, May 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Bipolar Disorder
 •Alert me on articles by topic

Fish Oils and Bipolar Disorder

A Promising but Untested Treatment

Arch Gen Psychiatry. 1999;56:413-414.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS issue of the ARCHIVES, Stoll and colleagues1 report innovative preliminary data on the putative mood-stabilizing properties of a fish oil containing {omega}3 fatty acids in the treatment of bipolar disorder (types I and II).2 Acting on the assumption that overactive cell-signaling pathways may be involved in the pathophysiological characteristics of bipolar disorder3-4 and the finding that {omega}3 fatty acids are associated with a general dampening of signal transduction pathways associated with phosphatidylinositol, arachidonic acid, and other systems,5 Stoll et al performed a controlled study to explore the mood-stabilizing effects of high-dose {omega}3 fatty acids.

In this study, subjects were randomly assigned to parallel groups after stratifying for sex, recent lithium use, and a history of rapid cycling. The primary outcome measure was the duration of time to exit the blinded phase of the study for treatment of an emerging mood episode; the decision to end treatment was at . . . [Full Text of this Article]


RELATED ARTICLES

Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Andrew L. Stoll, W. Emanuel Severus, Marlene P. Freeman, Stephanie Rueter, Holly A. Zboyan, Eli Diamond, Kimberly K. Cress, and Lauren B. Marangell
Arch Gen Psychiatry. 1999;56(5):407-412.
ABSTRACT | FULL TEXT  

In Reply
Andrew L. Stoll and Lauren B. Marangell
Arch Gen Psychiatry. 1999;56(5):415-416.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?
Rapoport and Bosetti
Arch Gen Psychiatry 2002;59:592-596.
ABSTRACT | FULL TEXT  

Protective Effect of Arachidonic Acid on Glutamate Neurotoxicity in Rat Retinal Ganglion Cells
Kawasaki et al.
IOVS 2002;43:1835-1842.
ABSTRACT | FULL TEXT  

Fish Consumption, Depression, and Suicidality in a General Population
Tanskanen et al.
Arch Gen Psychiatry 2001;58:512-513.
FULL TEXT  

A Natural Thymoleptic?
JWatch Psychiatry 1999;1999:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.